Authors

• Gøri Perminow (ORCID: https://orcid.org/0000-0002-4158-372X)
• Robert Kruse (ORCID: https://orcid.org/0000-0003-1785-8540)
• Åsa V. Keita (ORCID: https://orcid.org/0000-0002-6820-0215)
• Carl Marten Lindqvist
• Niklas Nyström (ORCID: https://orcid.org/0000-0002-2487-8104)
• Manuela Zucknick (ORCID: https://orcid.org/0000-0003-1317-7422)
• Igor Bazov (ORCID: https://orcid.org/0000-0003-4388-1656)
• Samira Salihović (ORCID: https://orcid.org/0000-0001-5752-4196)
• Randi Opheim
• Mauro D'Amato
• Svend Andersen
• M Carlson
• O Øyås
• C Olbjørn
• M Magnusson
• C Bache-Wiig Mathisen
• Lena Öhman
• Johan D. Söderholm
• Vendel A. Kristensen
• Jonas Halfvarson
• Marte Lie Høivik
• Dirk Repsilber

Institutions

• Linköping University (SE)
• Ikerbasque (ES)
• Uppsala University (SE)
• Oslo University Hospital (NO)
• Karolinska University Hospital (SE)
• Uppsala University Hospital (SE)
• University of Oslo (NO)
• University of Skövde (SE)
• Örebro University (SE)
• Akershus University Hospital (NO)
• Sykehuset i Vestfold (NO)
• Karolinska Institutet (SE)
• CIC bioGUNE (ES)
• Lovisenberg Diakonale Sykehus (NO)
• University of Gothenburg (SE)

Publication Details

Journal

Journal of Pediatric Gastroenterology and Nutrition

Published

2026-02-16

DOI

https://doi.org/10.1002/jpn3.70379

Primary Topic

Inflammatory Bowel Disease

Type

article

Field-Weighted Citation Impact

0.00

Funders

• Bristol-Myers Squibb
• Eli Lilly and Company
• Pfizer
• AstraZeneca
• Celgene
• Danone
• Stiftelsen för Strategisk Forskning
• VINNOVA
• Vetenskapsrådet
• NordForsk
• Norges Forskningsråd
• Vifor Pharma
• Stiftelsen för Strategisk Forskning
• Tillotts Pharma